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Platelet-rich plasma (PRP) is a new approach to tissue regeneration and it is becoming a valuable adjunct to
promote healing in many procedures in dental and oral surgery, especially in aging patients. PRP derives from the
centrifugation of the patient's own blood and it contains growth factors that influence wound healing, thereby
playing an important role in tissue repairing mechanisms. The use of PRP in surgical practice could have beneficial
outcomes, reducing bleeding and enhancing soft tissue healing and bone regeneration. Studies conducted on
humans have yielded promising results regarding the application of PRP to many dental and oral surgical
procedures (i.e. tooth extractions, periodontal surgery, implant surgery). The use of PRP has also been proposed in
the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with the aim of enhancing wound
healing and bone maturation. The aims of this narrative review are: i) to describe the different uses of PRP in dental
surgery (tooth extractions and periodontal surgery) and oral surgery (soft tissues and bone tissue surgery, implant
surgery and BRONJ surgery); and ii) to discuss its efficacy, efficiency and risk/benefit ratio. This review suggests that
the use of PRP in the alveolar socket after tooth extractions is certainly capable of improving soft tissue healing and
positively influencing bone regeneration but the latter effect seems to decrease a few days after the extraction. PRP
has produced better results in periodontal therapy in association with other materials than when it is used alone.
Promising results have also been obtained in implant surgery, when PRP was used in isolation as a coating material.
The combination of necrotic bone curettage and PRP application seem to be encouraging for the treatment of
refractory BRONJ, as it has proven successful outcomes with minimal invasivity. Since PRP is free from potential risks
for patients, not difficult to obtain and use, it can be employed as a valid adjunct in many procedures in oral and
dental surgery. However, further RCTs are required to support this evidence.
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Periodontal surgery, Implant surgery, BRONJIntroduction
Research in dental and oral surgery often involves mate-
rials and procedures which are capable of improving
clinical outcomes in terms of percentages of success.
The goal of this research was to find a treatment ap-
proach which could reduce bleeding, promote effective
bone regeneration and rapid soft-tissue healing by
employing resources which are easy to use at a modest
cost.* Correspondence: antonino.albanese@unipa.it
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reproduction in any medium, provided the orPlatelet rich plasma (PRP) is a new approach to tissue
regeneration: it is widely used in various surgical fields,
including head and neck surgery, otolaryngology, cardio-
vascular surgery, and maxillofacial surgery. Commonly,
PRP is used in a gel formulation, which is formed by
mixing PRP (derived from the centrifugation of autolo-
gous whole blood) with thrombin and calcium chloride.
PRP gel includes a high concentration of platelets and a
native concentration of fibrinogen [1,2].
During wound healing, platelets are among the first
cells to respond at a wound site, being critical to the ini-
tiation of this process. Besides their procoagulant effects,
platelets form a rich source of important growth factors,al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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forming growth factor-b (TGF-b) 1 and 2, and vascular
endothelial growth factor (VEGF); all of these are in-
volved in the angiogenic cascade which assists in hard
and soft tissue wound healing [3-5].
Recently, PRP has become a valuable adjunct to pro-
mote healing in many procedures in dental and oral
surgery. They include: ablative surgical procedures, man-
dibular reconstruction and surgical repair of the alveolar
cleft, treatment of infrabony periodontal defects and
periodontal plastic surgery, as well as procedures relat-
ing to the placement of osseointegrated implants. In
such procedures, the adhesive nature of PRP facilitates
the easier handling of graft material, with more predict-
able flap adaptation and hemostasis, and a more predict-
able seal than is the case with primary closure alone
[6-14]. Recently, the use of PRP has also been proposed
in the management of bisphosphonate-related osteo-
necrosis of the jaw (BRONJ) or avascular necrosis, which
is caused by other factors (e.g. radio-osteonecrosis), with
the aim of increasing wound healing and bone matur-
ation [15-21].
Aging patients are usually the elective patients for
these procedures. From a dental point of view, these pa-
tients could be considered as special needs patient,
requiring a specific approach; age is considered an im-
portant determinant of periodontal disease, which is the
main cause of tooth loss in adulthood. Moreover, elderly
patients are mostly subject to systemic diseases which
influence the response to surgical treatment in terms of
coagulation and tissue repair. The improvement in qual-
ity of life of aging patients in recent decades has deter-
mined a growing request for elective treatments and
devices which answer their specific needs contemporan-
eously [22,23].
The aims of this narrative review were: i) to describe
the different uses of PRP in dental surgery and oral sur-
gery; and ii) to discuss its efficacy, efficiency and risk/
benefit ratio. The different bioactive substances present
in PRP and the role played in the healing process will
also be elucidated.
Methods
As part of the review process, the literature was
searched for published studies relating to PRP and den-
tal surgery (e.g. alveolar wound healing and periodontal
surgery) and oral surgery (i.e. soft tissues, bone tissues,
and BRONJ surgery). A search of studies in the literature
was conducted according to the Dickersin’s search strategy
[24], using MeSH terms and text words. An extensive
search of bibliographical databases included: MEDLINE
(1966– November week 4, 2012); EMBASE (1988–
November week 4, 2012); the Cochrane Library and Best
Evidence (1991– third quarter 2012); the ISI Web ofScience (1965– November week 4, 2012); PubMed (1966–
November week 4, 2012); Lilacs (1982– November week
4, 2012); the Cochrane Central Register of Controlled
Trials (1991–third quarter 2012) and CINAHL (1982–
November week 4, 2012). The following keywords were
used in searching for references: PRP, Piastrinic Gel, PRF,
Oral surgery, Dental surgery, Periodontal surgery, Oral
medicine, Wound Healing, ONJ, BRONJ. Other sources
were taken from the reference list of selected Papers.
All RCTs and literature reviews were considered. Case
reports were used for the BRONJ session only due to the
absence of original articles relating to this topic. Articles
published in English from 2007 to December 2012 were
considered for the discussion of PRP efficacy and effi-
ciency. Studies based on in vitro trials were excluded
and a total of 68 articles were finally considered. The
quality of RCTs was assessed, taking into consideration
the degree of bias, the presence of randomization and
blindness.
This Review is structured into three main sections: the
first section deals with the action mechanism of PRP on
tissue wound healing; the second describes the use of
PRP in dental surgery (tooth extractions and periodontal
surgery) and oral surgery (soft tissues and bone tissue
surgery, implant surgery and BRONJ surgery) and its ad-
vantages in terms of efficacy and efficiency. The studies
selected in this section are listed in Tables 1, 2, 3 and 4
for dental surgery and oral surgery respectively. A quali-
tative scale with three different scores (weak, moderate
and strong) was used in the Tables to evaluate the PRP
effect. The method of scoring the PRP effect as used in
the Tables, is based on the statistical significance of the
efficacy of PRP, as reported in the analyzed studies: a.
weak: effective but not statistically significant; b. moder-
ate: borderline efficacy, statistically significant; c. strong:
efficacy statistically significant. The third and final sec-
tion discusses the risk/benefit ratio associated with the
use of PRP.
The PRP action mechanism
Platelet-rich plasma (PRP) is defined as a high concen-
tration of autologous platelets in a small volume of au-
tologous plasma [25,26]. Specifically, PRP is a platelet
concentration with at least 1,000,000/1 L in a 5 mL vol-
ume of plasma, when normal human platelet counts in
the blood range from 150,000/1 L to 350,000/1 L. The
platelets contained in this concentrate of autologous
plasma release their alpha granules after the coagulation
process has been locally trigged in the wound site. These
alpha granules contain a cocktail of growth factors
which promote proliferation, chemotaxis and the differ-
entiation of cells, which are essential to osteogenesis.
Thus, besides its procoagulant effect, PRP is a source of
growth factors involved in initiating and sustaining wound
Table 1 Summary of the RCTs using PRP in tooth extraction
Authors Year of
publication
Number of
patients
Follow-up
(wks)
Main results Effect of
PRP
Alissa et al. 2010 23 12 Statistical significant improvement in soft and bone tissuehealing; statistically
significant reduced post-operative pain and complications
strong
Ogundipe
et al.
2011 11 12 Statistical significantly reduced pain; improvement in swelling/interincisal mouth
opening and bone density but not statistically significant
moderate
Ruktowski
et al.
2010 12 25 Early and significant increased radiographic density over baseline measurements in
PRP- treated sites; no significant improvement in post-operative pain and bleeding
after PRP application.
moderate
Celio-
Mariano
et al.
2012 15 1-4-8-12-
24
Significant improvement in bone healing in PRP- treated sites strong
Arenaz-
Bua et al.
2012 82 12-24 No acceleration of bone formation after PRP treatment. No improvement in pain,
swelling, trismus and infection.
weak
Gurbuzer
et al.
2008 12 1-4 No increased osteoblastic activity in PRP treated sites weak
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proliferation, and increasing tissue vascularity [27].
Platelet-rich plasma gel is formed by mixing PRP (de-
rived from the centrifugation of autologous whole blood)
with thrombin and calcium chloride. Adding thrombin
and calcium chloride to PRP automatically activates
the alpha granules to release the following biological
growth factors: platelet-derived growth factor (PDGF),
transforming growth factor-beta (TGF-b), vascular
endothelial growth factor (VEGF), insulin- like growth
factor I, epidermal growth factor (EGF) and epithelial
cell growth factor [3].Table 2 Summary of the RCTs using PRP in periodontal surge
Authors Year of
publication
Number of
patients
Treatment Follow-up
(wks)
Pradeep
et al.
2009 20 Treatment of
furcation defects
24
Menezes
et al.
2012 60 Treatment of
infrabony defects
48-192
Saini et al. 2011 20 Treatment of
infrabony defects
12-24-36
Bharadwaj
et al.
2011 10 Treatment of
infrabony defects
24
Ozdemir
et al.
2012 14 Treatment of
infrabony defects
24
Harnack
et al.
2009 22 Treatment of
infrabony defects
24 N
Rodrigues
et al.
2011 Treatment of
infrabony defects
12-24-36 B
Dori et al. 2008 26 Treatment of
infrabony defects
48
Dori et al. 2009 30 Treatment of
infrabony defects
48
Piemontese
et al.
2008 60 Treatment of
infrabony defects
48
Keceli et al. 2008 40 Root coverage 6-36-48The major effects of PRP are derived from PDGF,
which has been identified as an important protein for
hard- and soft-tissue healing. PDGF has been shown to
stimulate chemotaxis, mitogenesis and the replication of
stem cells at the site of a wound to the site of tissue in-
jury. This results in the formation of matrix bone and
angiogenesis by stimulating increased levels of VEGF.
This in turn may lead to accelerate soft-tissue healing
due to neo-vascularization. PDGF also stimulates the
production of fibronectin, a cell adhesion molecule
used in cellular proliferation and migration during
healing, including osteoconduction and hyaluronic acid,ry
Main results Effect of
PRP
No complete closure of furcation defects weak
Positive effect of PRP used with other graft materials in
infrabony defects but not when used alone
weak
Positive effect of PRP used with other graft materials in
infrabony defects
moderate
Significant improvement in PD, CAL and bone radio-density strong
Positive effect of PRP used with other graft materials in
infrabony defects but not when used alone
weak
o improvement in PPD and CAL derived from the adjunt of
PRP to other graft material
weak
etter clinical results for PRP used with other graft materials in
infrabony defects than with PRP used on its own
weak
No adjunctive benefit with the use of PRP weak
No adjunctive benefit with the use of PRP weak
No adjunctive benefit with the use of PRP weak
No adjunctive benefit with the use of PRP weak
Table 3 Summary of the RCTs, using PRP in soft/bone tissue surgery and implant surgery
Authors Year of
publication
Number of
patients
Treatment Follow-up
(wks)
Main results Effect
of PRP
Anitua et al. 2006 295 Implantology 8 Improvement in implant prognosis strong
Anand et al. 2012 11 Implantology 12-24-36-48 Improved early bone apposition around the implant strong
Gentile
et al.
2010 15 Reconstructive surgery
of the jaw
2-4-12-24 Efficacy of PRP treatment in terms of patient satisfaction
and low-morbidity
strong
Wojtowicz
et al.
2007 16 Augmentation of
mandibular bone
12 PRP is more effective than bone marrow, containing
CD34+ cells
strong
Daif 2012 24 Bone regeneration of
mandibular fractures
1-12-24 Direct application of the PRP along the fracture lines may
enhance bone regeneration in mandibular fractures
strong
Khairy et al. 2012 15 Sinus lift 12-24 PRP- enriched bone grafts were associated with superior
bone density at 6 months post grafting
strong
Poeschl
et al.
2012 14 Sinus lift 28 Increased new bone formation when PRP was used strong
Cabbar
et al.
2011 10 Sinus lift 28 No statistically significant differences were observed weak
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modelling [28].
Other cytokines released by PRP alfa granules are
TGF-b1 and TGF-b2, both of which are involved in
connective tissue repair and bone regeneration. Their
most important role appears to be to stimulate fibroblast
chemotaxis and the production of collagen and fibronec-
tin by cells while inhibiting collagen degradation byTable 4 Summary of the case reports using PRP in the BRONJ
Authors Year of
publication
Number of
patients
Type of lesion Trea
Curi et al. 2007 3 Jaw lesions
Lee et al. 2007 2 Complications of dental
implants: oral sinus
communication and
lesion on the jaw ramus
Closur
commun
large pa
flap over
debridm
Adornato
et al.
2007 12 Soft tissue ulcerations
and bone exposure
Marginal
the
Cetiner
et al.
2009 1 Exposed necrotic bone
in the alveolus
Margin
mandib
Bocanegra
et al.
2012 8 Exposed necrotic bone
in the mandibula and
maxilla
Removal
curettag
Mozzati
et al.
2012 32 Jaw lesions Resection
Coviello
et al.
2012 7 Jaw lesions Surgica
sedecreasing proteases and increasing protease inhibitors.
In vitro and in vivo studies have also shown that TGF in-
creases the proliferation of mesenchymal stem cells and
osteoblasts, leading to bone regeneration. Specifically,
TGF-b2 has been shown to increase osteoblast and
osteoclast activity. An increase in TGF-b2 may acceler-
ate bone regeneration by controlling the activity of oste-
oblasts and osteoclasts [29,30].surgery
tment options Follow-up
(Mths)
Main results Effect of
PRP
6-8 Resolution of all lesions strong
e of the oroantral
ication by rotating a
latally-based pedicle
the defect; surgical
ent of the lesion of
the ramus
6-9 Resolution of pain and
complete closure of
exposed bone
strong
resection limited to
alveolar bone
6 Ten patients showed
complete soft tissue
healing
strong
al resection of the
ular necrotic bone
6 Complete healing of the
oral mucosa and alveolar
bone at the surgical site
strong
of necrotic bone and
e of the underlying
bone
14 Fast mucosal healing,
reduced need for
analgesics and resolution
of mouth lesions, without
evidence of exposed
bone.
strong
of the necrotic bone The orthopanoramic X-ray
and computed
tomography performed
before and after surgery
showed successful
outcomes
strong
l debridement and
questrectomy
3 Improvement in wound
healing and reduction of
bone exposure
strong
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The effects of PRP on healing the alveolar socket after
tooth extraction
Tooth extraction is a common dental procedure which
involves severely decayed, periodontally affected, not-
restorable or impacted teeth. These procedures can be
associated with significant postoperative pain, particu-
larly when third impacted molars are extracted. Further-
more, prolonged bleeding can be experienced by patients
especially by those undergoing anticoagulant therapy [31].
To address post-operative discomfort and to enhance
tissue repair mechanisms, many procedures (i.e. fibrin
sponge, biostimulation with LASER) have been performed
which promote the healing process [32,33].
Recently, the use of PRP has been proposed as a way
of obtaining high concentrations of growth factors in-
volved in tissue healing and regeneration. The thera-
peutic strategy of this approach is to promote the
process of tissue repair, improving the quality of healing
and healing time [8]. However, very few studies have
been carried out on humans and contradictory results
have been produced regarding the efficacy of PRP.
Promising results were reported by Alissa et al. (2010),
who conducted a pilot study on the effect of PRP on the
healing of the hard and soft tissues of extraction sockets.
Soft tissue healing was significantly improved in patients
treated with PRP compared with patients of the control
group (no treatment). Moreover, patients untreated with
PRP experienced complications (dry sockets and acutely in-
flamed alveolus), which were considered to be borderline
statistically significant. Radiographic evaluation revealed a
statistically significant difference only for sockets with a
dense homogeneous trabecular pattern. Of interest, Alissa
et al. (2010) also analyzed the post-operative pain of pa-
tients of the two groups (treated and untreated) and they
reported significantly more pain in the control group, espe-
cially in the first three days post intervention [34].
A significant response to pain in patients undergoing a
surgical extraction of a single impacted third molar and
using PRP was also reported by Ogundipe et al. (2011).
Moreover, an improvement in swelling and the
interincisal mouth opening was obtained in these pa-
tients: the scores for lamina dura, trabecular pattern,
and bone density were much improved among patients
in the PRP group, even if this difference was not statisti-
cally significant [35].
Similar findings have been reported by Ruktowski et al.
(2010) who used digital radiography and Computer Tom-
ography (CT) scan analysis to track changes in radio-
graphic density at PRP- treated sites in comparison to
ipsilateral not-PRP treated sites. The PRP- treated sites
demonstrated early and a significant increased radiographic
density over baseline measurements following tooth re-
moval. The greatest benefit attributed to PRP is during theinitial 2-week post-operative healing time period: 6 weeks
for control extraction sites to reach comparable bone dens-
ity were required whereas PRP- treated sites achieved this
at week 1. Post-operative pain and bleeding were not sig-
nificantly affected by PRP application. [36]. Likewise, a
more recent study by Celio-Mariano et al. (2012) showed a
greater radiographic bone density in the PRP group,
thereby demonstrating a significant improvement in bone
healing in the sockets after extraction of mandibular third
molars as compared to the control group [37].
In a prospective split-mouth study conducted by
Arenaz-Bua et al. (2010) the efficacy of PRP in promot-
ing bone regeneration after third molar extraction was
analyzed. The Authors observed no further acceleration
in bone formation at 6 months nor did they observe sta-
tistically significant differences between the groups re-
garding pain, swelling, trismus and infection throughout
the post-operative period. [38]. Similarly, in a study by
Gurbuzer et al. (2008) (using scintigraphy), the applica-
tion of PRP on its own to soft tissue impacted mandibu-
lar third molar extraction sockets failed to increase the
osteoblastic activity in post-surgical weeks 1 and 4 in
comparison to non-PRP-treated sockets [39].
The above review of the literature suggests that the
use of PRP in the alveolar socket after tooth extractions
is certainly capable of improve soft tissue healing but
there is insufficient evidence which supports the efficacy
of PRP in improving bone regeneration. Similarly, the ef-
ficiency of PRP is controversial since the use of PRP in
tooth extraction sites seems to influence the early phase
of bone healing, thereby facilitating and accelerating
bone formation in the initial period after tooth extrac-
tion, its influence decreasing after a few days. Not uni-
vocal results were also obtained for post-operative pain
but conclusive considerations in terms of efficacy and ef-
ficiency could not be formulated. The aforementioned
studies are listed in Table 1.
The use of PRP in periodontal surgery
The growth factors present in PRP are capable of forming
a fibrin clot, promoting fibroblast proliferation and up-
regulating collagen synthesis in the extracellular matrix.
Thus, the use of PRP at injury sites might be able to pro-
mote wound healing and the regeneration of periodontal
soft tissues [36]. Moreover, the ability of these factors to
accelerate bone repair by increasing the mitosis of osteo-
blasts and tissue vascularity might be useful in the treat-
ment of infra-bony defects [40,41]. However, the
therapeutic efficacy of PRP in periodontal therapy still re-
mains controversial.
The results of a recent systematic review regarding the
efficacy of PRP in periodontal therapy have revealed that
it is capable of improving gingival recession but not
clinical attachment level in chronic periodontitis [42].
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on the treatment of mandibular furcation defects, have
reported the lack of complete closure of furcation de-
fects despite a significant improvement; this implies a
limited role for autologous PRP as a regenerative mater-
ial [43]. However, the efficacy of PRP on its own is diffi-
cult to evaluate since the majority of studies have been
conducted by testing PRP in combination with graft ma-
terials in order to enhance the outcome of regenerative
surgery. Moreover, a barrier membrane was used to
cover the defects in most clinical studies and, thus, the
effects of PRP may have been masked by the effects of
the barrier.
The results of the systematic review by Del Fabbro et
al. (2011) revealed that PRP may exert a positive ad-
junctive effect when used in combination with graft ma-
terials for the treatment of intrabony defects. However,
no significant benefit of PRP was found for the treat-
ment of gingival recession [44]. Similarly, two controlled
clinical trials investigating the efficacy of PRP combined
with other graft materials in the treatment of intra-
osseous periodontal defects reported a significantly more
favorable clinical improvement in periodontal sites
treated with the combination of PRP and the graft ma-
terial than in those treated with the graft material alone
[45,46]. Contemporaneously, Bharadwaj et al. (2011)
found that the adjunct of PRP to bone graft appeared to
be beneficial in the treatment of human periodontal
intrabony defects. [47].
Different results have been reported by other Authors,
who showed no significant benefits regarding the add-
itional use of PRP to graft materials in the treatment of
infra-bony defects. Ozdemir et al. (2012) showed that
PRP combined with a graft material was effective in the
treatment of intrabony defects after a 6-month healing
period but no additional statistically significant improve-
ments were observed when PRP was used [48]. Similar
results were reached by Harnack et al. (2009) using the
same combination of materials [49]. Rodrigues et al.
(2011) concluded that both PRP and PRP combined with
bovine anorganic bone mineral (ABM) resulted in a sig-
nificant clinical improvement for the treatment of hu-
man periodontal intrabony defects but there was a
preponderance of improved clinical results with the
addition of ABM to PRP [50]. No additional effects were
found by Döri et al. (2008, 2009) and Piemontese et al.
(2008). Throughout all their studies, they concluded that
the use of PRP failed to enhance the results obtained
with the use of the graft material used on its own
[51-53].
Few clinical comparative studies have investigated the
use of PRP in the treatment of gingival recession. Keceli
et al. (2008) did not reveal promising results and nor did
they observe differences in clinical outcomes betweenconnective tissue grafts (CTG) and a CTG-PRP combin-
ation [54]. The results of this analysis reflect the limited
and heterogeneous data available and suggest that the
specific selection of agents/procedures combined with
PRP could be important. The aforementioned studies are
listed in the Table 2.
The employ of PRP in oral surgery
The use of PRP in soft tissues and bone tissues surgery and
implant surgery
Animal and human studies have demonstrated that PRP
enhances and accelerates soft tissue repair and bone re-
generation [3,55]. In the field of bone tissue surgery, a
recent study by Daif (2012) investigated the effect of au-
tologous PRP on bone regeneration in mandibular frac-
tures. He concluded that direct application of the PRP
along the fracture lines may enhance bone regeneration
[56]. Wojtowicz et al. (2007) compared the effects of
stimulating the osteogenesis of the alveolar bone
by transplants of autologous bone marrow and freshly-
isolated mononuclear cells from bone marrow, con-
taining CD34+ cells and PRP. It was shown that newly-
formed bone increased under the influence of PRP. This
treatment was more effective than that using the popula-
tion of CD-34 bone marrow- derived stem cells [57].
A Cochrane review of Esposito et al. (2010) concluded
that PRP treatment did not seem to improve the clinical
outcome of sinus lift procedures with autogenous bone
or bone substitutes [58]. In addition, a study by Khairy
et al. (2012) evaluated the bone quality in sinus which
had been augmented with autogenous bone with or
without PRP. The conclusion was that enrichment with
PRP did not significantly improve bone density at
3 months post grafting but PRP- enriched bone grafts
were associated with superior bone density at 6 months
post grafting [59]. Poeschl (2012) obtained successful re-
sults when PRP was used in combination with a graft
material in maxillary sinus augmentation [60]. Cabbar
(2011) et al. compared a bovine bone xenograft with
PRP and without PRP to augment the human maxillary
sinus in preparation for receiving dental implants. The
conclusion of this study stated was that the combination
of the xenograft and PRP did not have any effect on new
bone formation and implant stabilization [61].
The preparation of PRP, as applied to an implant sur-
face, adheres to metal and might create a new dynamic
surface which could potentially show biological activity.
In 2006, Anitua showed that the osseointegration of im-
plants was enhanced by coating the implant surface with
PRP prior to insertion into the alveolus [62]. Similarly, Gen-
tile et al. (2010) reported their experience on 15 cases, in-
cluding reconstructive surgery of the jaw, post-extraction
alveolar bone regeneration, and oral implantology. The
results of their study revealed the efficacy of the PRP
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and low-morbidity [63]. Anand et al. (2012) have recently
proposed that the use of a novel technique (of coating the
implant with PRP) could improve the prognosis of the
treatment regarding an immediate loading protocol [64].
The results of these studies demonstrate that PRP is
effective in soft tissue healing and bone regeneration.
The combination of PRP application with other biomate-
rials seems to be promising as regards sinus lifting, but
the results depend on the material used. Promising re-
sults have also been obtained in implant surgery, using
PRP on its own as a coating material. The aforemen-
tioned studies are listed in Table 3.
The use of PRP in BRONJ surgery
Some researchers have proposed the use of PRP in
BRONJ surgery [15-21]. BRONJ is currently recognized
as a significant complication, which is related to the use
of bisphosphonates (BPs), a widely-used class of drugs
employed in the preventative treatment of various path-
ologies joined by the same alteration of bone turn-over
(i.e. osteoporosis, bone metastasis, associated with solid
tumours and multiple myeloma, malignant hypercalce-
mia). BPs are capable of inhibiting osteoclast-mediated
bone resorption, also displaying anti-angiogenetic activ-
ity. The bones of patients treated with BPs are, therefore,
poorly vascularized and poorly supplied with the sub-
stances necessary for wound healing [65,66].
The use of these drugs could delay the onset of
BRONJ, which is defined as an avascular area of necrotic
bone in the maxillofacial area, with or without exposed
bone. This area of osteonecrosis always appears in the
traumatized bone. Although some of the cases reported
were asymptomatic, most of them resulted in complica-
tions, such as an altered sensation in the affected area (e.g.
mandibular alveolar nerve), purulent exudates, oral-
cutaneos fistula, and mandibular fractures [65]. BRONJ
management is currently controversial, ranging from
medical to surgical treatment, with no definitive standard
of care. Indeed, the response to radical surgery is less pre-
dictable than in other situations involving bone necrosis,
such as radiotherapy or osteomyelitis [67]. Aggressive sur-
gical debridement is also controversial due to the risk of
worsening bone exposure. Occasionally, the bone is left
exposed due to the difficulty of treating the lesion [68].
PRP therapy has been proposed as a complement to
conservative surgery in order to enhance bone healing.
The rationale for the employment of PRP in patients af-
fected by BRONJ is based on the thesis that the presence
of growth factors (usually repressed by BPs) constitutes a
substitute stimulation to bone healing, which is similar to
physiological healing. The growth factors in PRP might ac-
celerate epithelial wound healing, decrease tissue inflam-
mation after surgery, improve the regeneration of boneand soft tissues, and promote tissue vascularization. The
additional advantages related to the use of this product are
its biocompatibility and safety, as an autologous product
[1,3].
Few case series studies relating to use of PRP in
treating BRONJ have been published: Cetiner et al.,
2009 described a case of zoledronate-associated BRONJ
after tooth exodontia in a 68-year-old man with multiple
myeloma, which was treated with surgical debridement
plus PRP with a positive outcome after a 6-month
follow-up period [15]. Curi et al., 2007 reported using
this treatment in three cases of jaw lesions, which were
followed up for 6 months in two cases and 8 months in
one [16]. Lee et al., 2007 reported two cases which were
successfully treated, which were secondary to complica-
tions of dental implants: one involved left oral sinus
communication (with a 9-month follow- up period) and
the other case involved a lesion on the left jaw ramus
(6-month follow-up) [17].
In the study conducted by Bocanegra et al. (2012)
eight patients were selected and all improved over a
mean period of 3 weeks (2–4 weeks) after treatment
with: fast mucosal healing, a reduced need for analgesics
and a resolution of mouth lesions. These patients con-
tinued with follow-up visits, without any evidence of ex-
posed bone after 14 months [18]. Adornato et al. (2007)
treated twelve patients who presented with soft tissue ul-
cerations and bone exposure with measurements ranging
from 5 to 25 mm. These lesions had not responded to
six months of treatment with cleaning therapies, 0.12%
chlorhexidine rinses and intermittent antibiotic therapies.
These patients were treated with conservative marginal re-
sections of the alveolar bone with primary closure over
the bony defect, PRP and a resorbable membrane under
antibiotic coverage. After six months, ten patients showed
complete soft tissue healing with one patient displaying a
recurrence of epithelial dehiscence; another patient, with
recovery by secondary intention, did not show any regres-
sion of bone exposure [19].
Positive results were also obtained by Mozzati et al.
(2012), who conducted a study on 32 patients treated
with intravenous BPs for oncological pathologies affected
by BRONJ. The patients were treated by a resection of
the necrotic bone with primary closure of the mucosa
over the bony defect using PRP. The orthopanoramic
and computed tomography performed before and after
surgery revealed successful outcomes [20]. Similarly
Coviello et al. (2012), who reported the cases of 7 pa-
tients with multiple myeloma treated with BPs, con-
cluded that the use of PRP enhances wound healing and
reduce bone exposure and would be an effective treat-
ment protocol to use in BRONJ subjects [21]. The re-
sults of these studies showed that the combination of
necrotic bone curettage and PRP application seem to be
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an efficient standard treatment has not yet been es-
tablished, this combined approach can be considered a
treatment option as it has demonstrated successful out-
comes and minimal invasivity.
The risk/benefit ratio and the use of PRP
PRP is an autologous preparation, utilizing the patient’s
own blood in a significantly small quantity. For this
reason, it is safe and there have been no published refer-
ences relating to the risk of infections, disease transmis-
sion (such as HIV, hepatitis, or Creutzfeldt-Jacob disease),
immunogenic reactions or any other adverse effects which
exist with allografts or xenografts [69].
In the past, the use of bovine thrombin (an activator
which allows polymerization of fibrin into an insoluble
gel), used in the preparation of PRP, was associated with
the risk of life-threatening coagulopathies [42]. However,
the adverse reactions reported were related to the source
and quantity of thrombin used. The use of bovine
thrombin in PRP in low doses (<200 units), topically
with no entry into systemic circulation and already clot-
ted when coming into contact with human tissues,
would not be dangerous as an immunologic reaction.
[3]. Moreover, in the second generation platelet concen-
trate, PRP activation was effected using only calcium
chloride, thus eliminating the risk associated with
thrombin. No adverse effects linking the use of calcium
chloride have been reported in the literature [70,71].
Although no undesirable effects have been reported in
the many clinical cases subjected to PRP therapy, hy-
potheses as to the over-expression of growth factors and
their receptors related to tumour and dysplastic tissues
have been postulated. These hypotheses are founded on
the fact that growth factors appear to regulate different cel-
lular processes, such as mitogenesis, chemotaxis, cell dif-
ferentiation and metabolism. However, the phenomenon
leading to neoplastic growth requires more continuous
doses of growth factors over time than those applied in
PRP therapy and sufficient delivery, taking into account
that extracellular growth factors degrade within 7–10 days.
Moreover, there are previously existing alterations for de-
veloping a neoplasm and, in any case, the use of PRP
should be avoided: in patients with precancerous oral con-
ditions and in the vicinity of precancerous lesions (oral leu-
koplakia, erythroplasia or solar cheilitis); areas of oral
epithelial dysplasia; and in patients with a prior history of
exposure to carcinogens or primary oral squamous cell car-
cinoma [72].
The only disadvantage of PRP preparations would be
the cost versus the outcome benefit. The doubtful suc-
cess of PRP may not justify the cost to the clinician of
buying the PRP-processing system and the disposable
kits or the cost to the patient for paying for thistreatment. Furthermore, an additional but less important
inconvenience for the treatment would be that patients
have to be subjected to a venipuncture and blood draw-
ing procedure in preparation for PRP [1,3]. On the other
hand, PRP has the advantage to being easily obtainable
and not time-consuming for the patient and/or clinician.
Even if preparation of PRP involves an additional step to
the surgical procedure, it takes approximately 30 minutes
and is best performed by a surgical assistant under the
supervision of a trained dental surgeon. This can be
done simultaneously while performing the surgery, and
it, therefore, does not significantly increase the chair
time of the operator and the patient [3,47].
Conclusion
PRP preparations have been proposed for several uses in
dental and oral surgery. The ease with which these prep-
arations are used might be helpful to the dental profes-
sional in many surgical procedures, and their safety
might encourage their wide employment [1,3,47,69]. The
scientific evidence regarding the efficacy and efficiency
of PRP is still controversial, given the paucity of RCTs
relating to this topic and, of these, the majority has been
conducted using different graft materials and applying
different procedures.
This Review of the literature suggests that the use of
PRP in the alveolar socket after tooth extractions is cer-
tainly able to improve soft tissue healing and positively
influence bone regeneration but this latter effect seems
to decrease a few days after extraction. PRP has revealed
better results in periodontal therapy in association with
other materials than when it is used alone, suggesting
that the specific selection of agents/procedures com-
bined with PRP could be important [34-39].
Promising results have also been obtained in implant
surgery, using PRP on its own as a coating material. Fur-
thermore, the combination of PRP application with
other biomaterials seems to be favorable as regards sinus
lifting even if the choice of material used is critical in
this field [58-64]. The combination of necrotic bone cur-
ettage and PRP application seem to be encouraging for
the treatment of refractory BRONJ, as it has demon-
strated successful outcomes with minimal invasivity
[15-21]. Since it is free from potential risks to patients,
not difficult to obtain and use, PRP can be employed as
a valid adjunct to many procedures in oral and dental
surgery. However, further RCTs are required to support
the use of PRP in current practice.
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